DROPERIDOL - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for droperidol and what is the scope of freedom to operate?

Droperidol is the generic ingredient in four branded drugs marketed by Abraxis Pharm, Am Regent, Astrazeneca, Hikma, Hospira, Igi Labs Inc, Luitpold, Smith And Nephew, Solopak, Watson Labs, Rising, and Epic Pharma Llc, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for droperidol. Two suppliers are listed for this compound.

Sponsor	Phase
RenJi Hospital	N/A
Mercy Health Ohio	Phase 3
Lake Erie College of Osteopathic Medicine	Phase 3

Sponsor

Phase

RenJi Hospital

N/A

Mercy Health Ohio

Phase 3

Lake Erie College of Osteopathic Medicine

Phase 3

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Igi Labs Inc	DROPERIDOL	droperidol	INJECTABLE;INJECTION	072021-001	Oct 19, 1988		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	DROPERIDOL	droperidol	INJECTABLE;INJECTION	073521-001	Nov 27, 1991		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	DROPERIDOL	droperidol	INJECTABLE;INJECTION	073523-001	Nov 27, 1991		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Astrazeneca	DROPERIDOL	droperidol	INJECTABLE;INJECTION	072018-001	Oct 20, 1988		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	DROPERIDOL	droperidol	INJECTABLE;INJECTION	073520-001	Nov 27, 1991		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Smith And Nephew	DROPERIDOL	droperidol	INJECTABLE;INJECTION	071750-001	Sep 6, 1988		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Igi Labs Inc	DROPERIDOL	droperidol	INJECTABLE;INJECTION	072019-001	Oct 19, 1988		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

US Patents:	0
Tradenames:	4
Applicants:	12
NDAs:	24
Drug Master File Entries:	5
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	102
Clinical Trials:	43
Patent Applications:	6,667
What excipients (inactive ingredients) are in DROPERIDOL?	DROPERIDOL excipients list
DailyMed Link:	DROPERIDOL at DailyMed

Drug Class	Dopamine-2 Receptor Antagonist
Mechanism of Action	Dopamine D2 Antagonists